Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.306, 2001-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Make both amfebutamone and NRT available through the NHS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 271, 2000-01 ,pp. :
Access to resources
Recommend
Bupropion cost advantage over NRT
Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. :
Trastuzumab reimbursement decisions not equitable
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 525, 2007-01 ,pp. :
Reimbursement rules to be relaxed in Belgium
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 415, 2003-01 ,pp. :
Varenicline vanquishes NRT in battle for smoking cessation
Inpharma, Vol. 1, Iss. 1656, 2008-01 ,pp. :